TAYLOR KUHLMAN: Open Payments
NPI 1609486281 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 15 payments from 10 companies in 2025. Trend: 2023 $633 · 2024 $2,716 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $56 |
| QOL Medical, LLC | 2 | $55 |
| Madrigal Pharmaceuticals | 1 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| EVOKE PHARMA, INC. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 3 | $16 |
| VIVUS LLC | 1 | $15 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: Sucraid, RINVOQ, REZDIFFRA, RELISTOR, GIMOTI, OMVOH, ZENPEP, VOQUEZNA.
Industry payments across OH — which companies pay providers there.
